TrialThe Journal of infectious diseases2017

Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.

Supachai Rerks-Ngarm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.